Methylprednisolone Terminated Phase 2 Trials for Chronic Lymphocytic Leukaemia (CLL) / Small Lymphocytic Lymphoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01465334Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL